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Abstract
Fertility is markedly reduced in patients with chronic renal failure. For women with pre-existing
renal disease, pregnancy is associated with an increased rate of fetal complications and a
considerable risk of renal disease progression. Due to substantial improvements in antenatal and
neonatal care, fetal outcome has improved considerably in the last two decade.
A Saudi survey which examined the frequency of pregnancy among women in end stage renal
disease (ESRD) and undergoing regular hemodialysis (HD), showed an incidence of 7% over a five
year period (1.4 per year). This may reflect the cultural endorsement of having offspring.




A 37 year old Saudi female, 8th gravida with a history of a
single 2nd trimester abortion and six living offsprings. The
patient was started on regular HD at PSCKD in January
2006. Three months after maintenance hemodialysis she
presented with abdominal distension and 4 weeks history
of amenorrhea. She was found to be pregnant after meas-
urement of serum HCG, confirmed by a pelvi-abdominal
ultrasonography. Her dialysis prescription consisted of 3
extended weekly sessions (7 hours each) due to her refusal
of daily dialysis. Her eKt/V was between 3 to 3.7 (she was
passing 400 ml urine/day with estimated GFR of 4.9 ml/
min/1.73 m2). Her normalized protein catabolic rate
(nPCR) was 1.46; blood gas analysis revealed a pH of
7.36, HCO3 of 24.2 meq/L, serum calcium 2.26 mmol/L
and serum phosphate 1.17 mmol/L. As part of her medi-
cation the required dose of erythropoietin was increased
from a mean weekly dose of 8000 units to 14000 units
during pregnancy to maintain a hemoglobin level of 10
gm/dl. Iron was also increased from oral ferrous fumarate
(100 mg/day) to IV iron saccharate (100 mg/weekly). She
also received Calcium carbonate 1500 mg/day as a phos-
phate binder, multivitamins and folic acid. Her mean pre-
dialysis blood urea nitrogen (BUN) was 15.13 mg/dl. The
blood pressure was controlled without antihypertensive
medication. A boy weighing 2.3 kg was delivered by vagi-
nal delivery in the 30th week of gestation with uneventful
neonatal period.
Case 2
A 36 year old female patient, 9th gravida with 4 living off-
springs and four abortions. Her first pregnancy was com-
plicated by pre-eclampsia, nevertheless it was completed
successfully and the following 3 successful pregnancies
were uncomplicated. She had a history suggestive of
chronic glomerulonephritis.
During the first trimester of her 9th pregnancy (March
2006), she developed lower limb oedema and felt unwell
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with persistent nausea and vomiting. Her urinalysis
revealed proteinuria 3+ and her biochemical investiga-
tions revealed high serum creatinine (15.56 mg/dl) and a
BUN level of 74 mg/dl. The patient was diagnosed as a
case of ESRD. Renal biopsy was not done in view of the
history of chronic glomerulonephritis and the patient's
refusal. She was maintained on HD since that time. She
was transferred to our center at the 20th week of gestation
where HD was performed daily for 6 hours/session.
An eKt/V of 2 was achieved (the patient was passing 350
ml urine/day with estimated GFR of 4.07 ml/min/1.73
m2) with a mean pre-dialysis BUN of 12.65 mg/dl. Her
nPCR was 1.24 and blood gas analysis revealed a pH of
7.35, HCO3 of 23.1 meq/L, serum calcium 2.23 mmol/L
and serum phosphate 1.52 mmol/L. Her medications
consisted of; &#x03AC; methyl dopa (500 mg TID – with
dose adjustment when necessary for tight BP control:
below 120/80 mmHg), folic acid 5 mg OD and calcium
carbonate (600 mg TID). As expected, erythropoietin and
iron requirements were increased during her pregnancy
(erythropoietin from a weekly dose of 6000 to a mean of
14000 units and iron saccharate to 100 mg IV once every
week instead of 100 mg/day of oral ferrous fumarate). Her
serum albumin ranged between 2.8 and 3 gm/dl and her
hemoglobin ranged between 8.33 and 9.74 g/dl.
Following discussion with the obstetric team, in both
cases programmed adjustment of the dry weight was done
by revising the estimated dry weight weekly to an expected
weight gain during progression of pregnancy. In addition
to routine pregnancy care, fetal well-being was monitored
by way of serial ultrasound assessment of biophysical pro-
files, Doppler studies and estimated fetal weights. At 32nd
week's gestation a diagnosis of pre-eclampsia (based on
uncontrolled blood pressure – despite increased dose of
&#x03AC;-methyldopa – and development of proteinu-
ria) was settled. The patient was electively delivered by
cesarean section resulting in a single viable girl – weighing
1.7 kg – with an uneventful neonatal period.
Discussion
In 1971 Confortini et al. [1] reported the first successful
pregnancy in a woman on chronic HD.
Recent publications report pregnancy in 1–7% in women
on chronic dialysis [2]. Moreover, pregnancy in contem-
porary women on dialysis is more likely to be successful,
with 30–50% of pregnancies resulting in delivery of a sur-
viving infant [3].
The results of a survey of pregnancy in the HD population
of the Kingdom of Saudi Arabia (over 5 years – 1985 to
1990) showed a frequency of 7% (27 among 380 women
on HD) with 37% successful outcome (10 patients) [4].
Early diagnosis of pregnancy in ESRD requires careful
attention. Irregular menstrual cycles, amenorrhea, nausea
and elevated beta-subunit of human chorionic gonado-
tropin have been observed in some patients with renal
failure which may give a false-positive pregnancy test. A
late diagnosis delays the intensive antenatal care and
reduces the successful outcome [5].
In one of our cases, the symptoms of pregnancy were first
attributed to inefficient dialysis before pregnancy was
diagnosed. As urine testing for pregnancy is not reliable in
patients with chronic renal failure because of altered renal
clearance and the difference in the molecular forms of
beta-subunit of human chorionic gonadotropin measured
by different assays [6]. As recommended, we used abdom-
inal sonography to confirm pregnancy and assess gesta-
tional age as soon as we were informed about the
pregnancy. Therefore, in such cases we suggest a blood
pregnancy test [to estimate B subunit of human chorionic
gonadotrophin (HCG) in blood] to be done prior to any
abdominal x-ray if there an abdominal complaint.
The number of successful pregnancies in dialysis patients
has improved over the years [7]. The outcome is better in
patients who conceived before starting dialysis compared
with those who became pregnant while on dialysis [3].
In our view, these figures should be interpreted with cau-
tion for a number of reasons. Firstly, there are no compre-
hensive prospective studies of conception among women
with ESRD. Secondly, the literature addressing pregnancy
in women on dialysis is composed primarily of survey
studies, single center retrospective reviews, and case
reports. Thirdly, pregnancies ending in the first or second
trimester by elective or spontaneous abortions are varia-
bly included, thus reporting bias may confound the
results.
Since the 1980s, the infant survival rate has improved
from 20–30% [8] up to 50% in 2003 [2]. This is probably
due to the care provided by a multidisciplinary manage-
ment team, characterized by close collaboration between
patients, nephrologists, dialysis staff, obstetricians and
neonatologists.
Despite improved infant survival, half of pregnancies in
women on dialysis are not successful and the proportion
of neonatal deaths remains higher than in the general
population. Infants born to women on dialysis are usually
premature, with an average gestational age of 32 weeks.
Our finding is in agreement with earlier reports regarding
gestational age since we failed to prolong gestational age
beyond 32 weeks, despite the maximum multidisciplinary
care we tried to provide.Journal of Medical Case Reports 2008, 2:10 http://www.jmedicalcasereports.com/content/2/1/10
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Multiple causes of premature delivery exist, including pol-
yhydramnios, maternal hypertension and premature rup-
ture of the membranes [9]. Since increasing dialysis
frequency lowers predialysis BUN levels, adequate dialysis
may reduce the occurrence of polyhydramnios and thus
lower the risk of premature labor [5]. Increasing the dial-
ysis dose prolongs gestation, resulting in a higher infant
birth weight and thus an infant with better chance of sur-
vival [4].
Despite the fact that no randomized prospective trials of
pregnant women on dialysis exist, retrospective data sug-
gest maintaining predialysis BUN values – beyond 16 to
20 weeks – at ≤ 50 mg/dl is an appropriate goal [5]. Preg-
nant women on dialysis will generally require 16–24
hours of HD each week.
In one series, fetal mortality was directly proportional to
maternal BUN level, with no successful pregnancies occur-
ring in patients with BUN levels greater than 60 mg/dL
[2]. In our cases the mean pre-dialysis BUN was main-
tained at 15.13 mg/dl and 12.65 mg/dl respectively dur-
ing pregnancy, which may have contributed in part to the
successful outcome.
In the largest study to date, the Registry for Pregnancy in
Dialysis Patients reported a significant correlation
between hours spent on dialysis therapy and improved
fetal outcome. The increase in dialysis time seems to
improve the pregnancy outcome and offer several advan-
tages: It ensures less uremic environment to the fetus and
allows the mother more liberal diet (Potassium and pro-
tein), it may help to control hypertension and fluid intake
and may also reduce the amplitude of blood voulme and
electrolyte shifts [3]. This is consistent with our results as
in both cases dialysis treatment was intensified (up to
daily dialysis in one case) resulting in viable mature
babies.
Estimating appropriate target weights for pregnant
women on dialysis may be difficult. Allowances must be
made for fetal and placental growth as well as the 30%
increase in plasma volume that occurs with pregnancy.
After the first trimester, weight gain is usually linear and is
approximately 1 pound/week. Ultrafiltration goals can be
adjusted based on this expected pregnancy-induced
weight gain [9].
Similarly dialysate adjustment may be needed to maintain
appropriate levels of serum calcium and to avoid hypocal-
cemia and/or post-treatment hypercalcemia. Since the
placenta converts some 25-hydroxyvitamin D3 to 1, 25-
dihydroxyvitamin D3, adjustment of vitamin D may be
required during pregnancy and should be guided by
measurement of levels of vitamin D, parathyroid hor-
mone, calcium and phosphorus [10].
Anemia occurs during pregnancy and pregnant dialysis
patients require intensive anemia management. Erythro-
poietin has been given safely to pregnant dialysis patients
[10]. Erythropoietin doses need to be increased by
approximately 50% in order to maintain target hemo-
globin levels of 10–11 g/dl. The reason for the higher
erythropoietin doses is unknown, but increased vascular
volume with subsequent hemodilution and possibly
erythropoietin resistance (due to enhanced cytokine pro-
duction) during pregnancy may contribute [10]. This is
consistent with our observation, as erythropoietin doses
were increased (by more than 70% and 100% in case 1
and 2 respectively) to maintain hemoglobin level compa-
rable to that before pregnancy.
In addition, both intravenous iron [5] and heparin appear
to be safe during pregnancy however frequent monitoring
of iron stores is required and minimizing heparin dose is
recommended [10].
Hypertension is the most frequently reported maternal
complication in this population, occurring in 42–80% of
these women [11]. Antihypertensive medications are
often required to maintain maternal diastolic blood pres-
sure in the 80–90 mmHg range [9]. The mainstays of treat-
ment are methyldopa, B-blockers, and hydralazine. In
cases of severe hypertension, clonidine and calcium chan-
nel blockers have been used safely [11]. In one of our
cases, hypertension was difficult to control after 30 weeks
of gestation despite maximum dose of methyldopa, neces-
sitating elective termination.
However, the other case remained normotensive without
any antihypertensive medications throughout pregnancy
with intensified dialysis.
There is little information on the nutritional status of
pregnant dialysis patients; however 1 g/kg/day protein
intake plus an additional 20 g/day for fetal development
have been suggested [11]. Folate supplementation is
required, particularly early in fetal development and
replacement of water-soluble vitamins should be contin-
ued during pregnancy [11].
Maternal mortality is very low and rarely reported [3,4].
Cesarean section delivery is common among women on
dialysis and is most often prompted by premature rupture
of membranes.
In conclusion, we hereby report two cases of successful
pregnancy in 2 Saudi patients, the first case with chronic
renal failure maintained on chronic hemodialysis and thePublish with BioMed Central    and   every 
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second with pre-existing renal disease aggravated by preg-
nancy. We advise that all aspects of dialysis, including
duration, adequacy, nutrition, anemia, calcium and phos-
phate metabolism and BP control needs to be closely fol-
lowed throughout the course of pregnancy. Furthermore,
a successful pregnancy in woman on dialysis requires col-
laboration among nephrologists, dialysis unit staff and
obstetricians. Finally, since pregnancy can occur in
woman on dialysis, health care providers should discuss
fertility and contraception with their premenopausal dial-
ysis patients.
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